Previous 10 | Next 10 |
It's tough when any onetime highflier falls precipitously from its height. Such was the case with ambitious biotech Sesen Bio (NASDAQ: SESN) , which saw its share price decline by a queasy 42% on Monday following continued fallout from a very discouraging communication from the FDA....
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Surgalign Holdings (NASDAQ: SRGA ) stock is on the move Monday following news of the company’s CEO buying up shares of SRGA. Source: Shutterstock This news comes from filings with the U.S. Securities an...
Gainers: NanoVibronix (NASDAQ:NAOV) +47%. Enlivex Therapeutics (NASDAQ:ENLV) +20%. GoHealth (NASDAQ:GOCO) +16%. Travere Therapeutics (NASDAQ:TVTX) +16%. Collegium Pharmaceutical (NASDAQ:COLL) +16%. Auddia (NASDAQ:AUUD) +15%. AudioEye (NASDAQ:AEYE) +14%. Cohen & Company (NYSE:COHN) +14%. F...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips T-Mobile (NASDAQ: TMUS ) is investigating claims of a 2021 data breach that includes as much as 100 million customers’ information. Source: r.classen / Shutterstock.com Here’s everything you need t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sesen Bio (NASDAQ: SESN ) stock is taking a beating on Monday following a letter from the U.S. Food and Drug Administration (FDA). Source: Bukhta Yurii / Shutterstock.com The letter from the FDA is in regards ...
Gainers: NanoVibronix NAOV +44%, Nymox Pharmaceutical (NASDAQ:NYMX) +21%, Travere Therapeutics TVTX +20%, Enlivex Therapeutics ENLV +15%, Collegium Pharmaceutical COLL +11%. Losers: Sesen Bio SESN -35%, ESSA Pharma EPIX -32...
China Finance Online (NASDAQ:JRJC) -43% after receiving Nasdaq delisting notice and announces private placement of ordinary shares and warrants Sesen Bio (NASDAQ:SESN) -36% after FDA declines to approve Sesen Bio's Vicineum bladder cancer treatment Standard Lithium (N...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thank goodness. The weekend is finally here and the major indices managed to once again close at record levels — despite the ominous undertones of Friday the 13th. So before you log off to dream of a sunny day spent ...
Boston, Massachusetts--(Newsfile Corp. - August 13, 2021) - Block & Leviton is investigating Sesen Bio, Inc. (NASDAQ: SESN) for potential securities law violations. Investors who have lost money in their Sesen Bio investment should contact the firm to learn more about how they migh...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors in Sesen Bio (NASDAQ: SESN ) are certainly disappointed today. The biotech company is sharing some bad news with investors today, as the Food and Drug Administration (FDA) shoots down the company’s ne...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...